NCT02266524View on ClinicalTrials.gov

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

April 30, 2005

Conditions
Urination Disorders
Interventions
DRUG

Tamsulosin hydrochloride, very low dose

DRUG

Tamsulosin hydrochloride, low dose

DRUG

Tamsulosin hydrochloride, medium dose

DRUG

Tamsulosin hydrochloride, high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY